Results 11 to 20 of about 69,426 (314)

Current career situations of Chinese pharmacovigilance professionals working for pharmaceutical companies: an exploratory survey

open access: yesBMC Health Services Research, 2023
Background Pharmacovigilance in China has experienced rapid development in the past 30 years. The implementation of Good Pharmacovigilance Practice in China since the end of 2021 heralds a new era of pharmacovigilance affairs, which puts forward higher ...
Yalan Tang   +4 more
doaj   +1 more source

Evaluation of Pharmacovigilance System in Iran [PDF]

open access: yesInternational Journal of Health Policy and Management, 2022
BackgroundEvaluating a pharmacovigilance system helps identify its deficiencies and could facilitate measures to remedy and improve the quantity and quality of adverse drug reaction (ADR) reports and other opportunities for pharmacovigilance systems ...
Malahat Khalili   +6 more
doaj   +1 more source

How pharmacoepidemiology networks can manage distributed analyses to improve replicability and transparency and minimize bias [PDF]

open access: yes, 2020
Several pharmacoepidemiology networks have been developed over the past decade that use a distributed approach, implementing the same analysis at multiple data sites, to preserve privacy and minimize data sharing.
Brown, Jeffrey S.   +5 more
core   +2 more sources

Suvorexant (Belsomra® Tablets 10, 15, and 20 mg): Japanese Drug-Use Results Survey

open access: yesDrugs in R&D, 2018
Background We report on the results of a Japanese postmarketing drug-use survey of suvorexant (Belsomra®) tablets. Methods A survey with a ≤ 6-month observation period after the start of administration was conducted, targeting insomnia patients who were ...
Yuko Asai   +5 more
doaj   +1 more source

Bayesian model selection in logistic regression for the detection of adverse drug reactions [PDF]

open access: yes, 2015
Motivation: Spontaneous adverse event reports have a high potential for detecting adverse drug reactions. However, due to their dimension, exploring such databases requires statistical methods.
Marbac, Matthieu   +2 more
core   +2 more sources

Pharmacovigilance of Biosimilars [PDF]

open access: yes, 2013
In lieu of an abstract, here is the article\u27s first paragraph: Biotech industry forms the backbone of the current pharmaceutical products. Seven out of top ten anticipated drugs of the industry in 2014 will be biologics [1].
Chablani, Lipika
core   +2 more sources

Safety and Effectiveness of Molnupiravir (LAGEVRIO®) Capsules in Japanese Patients with COVID-19: Interim Report of Post-marketing Surveillance in Japan

open access: yesInfectious Diseases and Therapy, 2023
Introduction Molnupiravir is an oral antiviral drug that received special approval for emergency use in Japan on December 24 2021 for infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Masahiro Kimata   +4 more
doaj   +1 more source

Identification of International Society on Thrombosis and Haemostasis major and clinically relevant non-major bleed events from electronic health records: a novel algorithm to enhance data utilisation from real-world sources

open access: yesInternational Journal of Population Data Science, 2023
Introduction In randomised controlled trials (RCTs), bleeding outcomes are often assessed using definitions provided by the International Society on Thrombosis and Haemostasis (ISTH).
Alexander Hartenstein   +5 more
doaj   +1 more source

Linked health data for pharmacovigilance in children : Perceived legal and ethical issues for stakeholders and data guardians [PDF]

open access: yes, 2014
Peer reviewedPublisher ...
Bond, Christine M   +4 more
core   +2 more sources

Social media mining for identification and exploration of health-related information from pregnant women [PDF]

open access: yes, 1989
Widespread use of social media has led to the generation of substantial amounts of information about individuals, including health-related information.
Chandrashekar, Pramod Bharadwaj   +3 more
core   +8 more sources

Home - About - Disclaimer - Privacy